Printer Friendly

GLOBAL SETTLEMENT PROPOSED TO RESOLVE BREAST IMPLANT ISSUE

 MIDLAND, Mich., Sept. 9 /PRNewswire/ -- Representatives for both plaintiffs and defendants involved with silicone breast implants have been discussing a global settlement of the issue. The discussions have progressed to a point where a proposal has been developed and is under review.
 Under this proposal, industry participants, including manufacturers, raw material suppliers, insurance carriers, physicians, and other health care providers would jointly fund $4.75 billion over a 30-year period. How much each of these participants, including Dow Corning and its insurance carriers, would contribute to this fund is still to be determined.
 "There is only a proposal at this point," said Gary E. Anderson, Dow Corning executive vice president. "There are still many steps to go through and conditions to be met before a settlement can be implemented. For example, the defendants' managements, board of directors, and insurance carriers must review and support the funding of the proposal. Similarly, the plaintiffs' attorneys must review the proposal with other plaintiffs' attorneys and their clients. As the settlement process goes forward, it will include court-supervised public hearings to assure that the primary objective of a fair settlement for women with breast implants is achieved.
 "One of the things we at Dow Corning like about the proposal is that it would essentially act like a health insurance policy for women with implants," explained Anderson. "We also believe that any effective agreement must provide reasonable and timely options for women to resolve their claims or concerns, both now and in the future. It also must allow the research to continue so that any remaining scientific issues can be resolved."
 Dow Corning continues to discuss a global settlement agreement despite its belief that silicone continues to be the material of choice in many medical applications by the medical profession.
 "We're encouraged by the growing body of scientific evidence from research done outside of Dow Corning that shows no conclusive link between breast implants and disease," said Anderson. "However, a settlement would move the implant controversy from a divisive issue to a responsible resolution for all interested parties."
 At the present time, the potential financial impact on Dow Corning of the proposal is uncertain. Taking into consideration the possible outcomes of unresolved issues, management believes that the proposed settlement, if implemented, would likely have a material adverse effect on Dow Corning's results of operations in the period in which it is recorded and could possibly have a material adverse effect on the company's consolidated financial position.
 -0- 9/9/93
 /CONTACT: Kara Kuchinic-Wittenberg of Dow Corning, 517-496-5994/
 (DOW GLW)


CO: Dow Corning Corporation ST: Michigan IN: CHM MTC SU:

KR-ML -- DE009 -- 0150 09/09/93 09:06 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 9, 1993
Words:443
Previous Article:DOW EVALUATES IMPACT OF PROPOSED SETTLEMENT BY DOW CORNING
Next Article:FORD CUSTOMERS TO SEE MODERATE INCREASE IN 1994 VEHICLE PRICES
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters